US District Court
Ravgen Sues Illumina, Roche Alleging Infringement of Cell-Free DNA Testing Patents
Ravgen has alleged that several leading NGS-based non-invasive prenatal testing and oncology assays infringe two patents held by the firm.
Judge Allows Whistleblower Suit Against Myriad Genetics to Proceed
In January a federal court unsealed a False Claims Act suit from an industry insider that alleges a Myriad subsidiary engaged in a fraudulent kickback scheme.
BioMérieux's BioFire Diagnostics Sued; Coronavirus Tests Accused of Infringing Theranos Patents
Labrador Diagnostics, a firm controlled by an investment group that acquired Theranos' IP, alleged BioFire's FilmArray products infringe two patents.
US Appeals Court Overturns Roche Win in Illumina NIPT Suit
The US Court of Appeals for the Federal Circuit sent the case, which had been thrown out in December 2018, back to the trial court.
Guardant Health CEO Deleted Email Evidence After Lawsuit Deposition
A federal court said Guardant CEO Helmy Eltoukhy deleted emails pertaining to two similar cases, but it remains unclear whether he did so intentionally.